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Abstract
Glycosylphosphatidylinositols (GPIs) from several protozoan parasites are thought to elicit a detrimental stimulation of the
host innate immune system aside their main function to anchor surface proteins. Here we analyzed the GPI biosynthesis of
an avirulent Toxoplasma gondii type 2 strain (PTG) by metabolic radioactive labeling. We determined the biological function
of individual GPI species in the PTG strain in comparison with previously characterized GPI-anchors of a virulent strain (RH).
The GPI intermediates of both strains were structurally similar, however the abundance of two of six GPI intermediates was
significantly reduced in the PTG strain. The side-by-side comparison of GPI-anchor content revealed that the PTG strain had
only,34% of the protein-free GPIs as well as,70% of the GPI-anchored proteins with significantly lower rates of protein N-
glycosylation compared to the RH strain. All mature GPIs from both strains induced comparable secretion levels of TNF-a
and IL-12p40, and initiated TLR4/MyD88-dependent NF-kBp65 activation in macrophages. Taken together, these results
demonstrate that PTG and RH strains differ in their GPI biosynthesis and possess significantly different GPI-anchor content,
while individual GPI species of both strains induce similar biological functions in macrophages.
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Introduction
The obligate intracellular protozoan Toxoplasma gondii ranks
among the most common parasites of animals and humans, with
an estimated worldwide incidence of 30% of chronically infected
individuals [1]. The canonical lineages, designated types 1, 2, 3
(formerly I, II, and III) and the haplogroup 12, comprise the genus
Toxoplasma in Europe and North America [2,3,4]. These
haplogroups differ genetically by 1% or less but diverge in a
number of phenotypes such as growth, migration potential, and
most notably acute virulence in laboratory mice [5,6]. Type 1
strains are highly virulent and uniformly lethal with LD100 of ,10
parasites, whereas type 2 strains are avirulent in most, but not all,
inbred mouse lines with a median lethal dose (LD50) of ,103
parasites. Type 3 strains are typically avirulent with LD50$10
5
parasites [7,8].
Toxoplasma polymorphic effector molecules subvert key host
defense mechanisms and account for much of the strain-specific
difference in virulence in mice [9,10]. These are introduced during
invasion into the host cytosol from secretory compartments,
namely rhoptries and dense granules, and traffic to the host
nucleus and to the nascent parasitophorous vacuole membrane
(PVM). The high virulence of type 1 strains is thus largely due to
the rhoptry protein (ROP)18 kinase, the closely related ROP5
pseudokinase, and the ROP16 kinase [6,11,12,13,14]. The former
kinases target host immunity by disrupting the function of
immunity-related GTPase (IRG)-mediated parasite clearance in
macrophages, while this process is not affected by type 2 and 3
strains, where IRGs cause disruption of the PVM and subsequent
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parasite destruction [15,16,17]. The latter alters host gene
transcription through sustained activation of signal transducer
and activator of transcription (STAT)3/STAT6 and promotes
alternative macrophage activation (M2), thereby limiting protec-
tive Th1 responses, which in turn favor parasite growth, causing
possibly a secondary response that leads to cytokine-mediated
pathology [18,19,20,21]. This detrimental overstimulation of host
immunity is likely triggered by parasite components, such as
profilin, cyclophilin-18, and glycosylphosphatidylinositol (GPI)
anchors [22,23,24].
GPI anchors are common glycolipids in all eukaryotes that
mainly function to covalently anchor surface proteins to
membranes, while synthesized at much higher rates in parasitic
protozoa than in other eukaryotes [25]. Over the last two decades
many biological and immunological properties have been found
associated with GPI anchors and GPI-related molecules of
protozoan parasites [26,27,28]. Both protein-free GPIs and/or
several GPI-anchored proteins, including SAG1-related sequence
proteins (SRS) and SAG-unrelated surface antigens (SUSA) have
been reported to decorate the surface of all T. gondii life cycle
stages, however the molecular function and biological importance
of most surface proteins remain poorly defined [29,30,31,32,33].
The majority of known SRS and SUSA proteins have dual
functions, either as adhesins mediating initial host cell attachment,
and/or immune decoys eliciting or modulating inflammatory
responses during acute infection [29,30,31,33]. The GPI biosyn-
thesis has been shown to be essential for T. gondii viability but it
remains unknown whether the observed lethality is due to the lack
of protein-free GPIs, GPI-anchored proteins or both [34]. The
protein-free GPI intermediates from the virulent T. gondii RH
strain have been structurally analyzed and demonstrated to induce
a TLR2/TLR4/MyD88-mediated TNF-a production in macro-
phages that is dependent on the expression of galectin-3
[23,35,36,37]. In contrast, little was known about the structure
and the biological functions of GPIs from avirulent T. gondii
strains.
In this report, we characterized the GPI content and assessed
the biological function of individual GPI species of an avirulent
type 2 strain (PTG). We demonstrated that this strain possesses
significantly less GPI content, lower levels of GPI-anchored
proteins, and lower rates of GPI-anchored protein N-glycosylation
than the virulent RH strain, while protein-free GPIs of both strains
activate identical TLR signaling pathways and induce comparable
levels of inflammatory cytokines in macrophages.
Materials and Methods
Analysis, extraction, and purification of individual GPIs
GPIs of the strains RH and PTG of T. gondii were metabolically
labeled by incubating parasites grown in Mycoplasma-free Vero
(American Type Culture Collection, ATCC) cells, in 20 ml
glucose-free DMEM containing 20 mM sodium pyruvate and
supplemented with 0.5 mCi D-[6-3H]-glucosamine hydrochloride
(Hartmann Analytic GmbH, Braunschweig) for 6 h at 37uC in 5%
CO2 atmosphere. Remaining intracellular parasites were released
from host cells with the help of glass beads in a Mixer Mill
homogenizer (Retsch, Haan) and subsequently purified from host
cell debris by glass wool filtration [38]. Labeled and unlabeled
GPIs were purified from a determined number of parasites using
the method previously described to obtain both protein-free and
GPI-anchored proteins [39]. Briefly, glycolipids were extracted
with chloroform-methanol-water 10:10:3 (v/v), partitioned be-
tween water and water-saturated butan-1-ol, and precipitated
gently under a nitrogen stream. Finally, GPIs recovered from the
butan-1-ol phase were separated by thin-layer chromatography
(TLC) on Merck Si 60 HPTLC plates using chloroform-methanol-
hexane-water-acetic acid 10:10:3:2:1 (v/v) as solvent and D-
[6-3H]-glucosamine labeled GPIs used as tracers. Chromatograms
were scanned for radioactivity using a Berthold LB 2842 linear
analyzer and areas corresponding to individual GPIs [35] were
scraped off, re-extracted with chloroform-methanol-water 10:10:3
(v/v), and recovered in the butan-1-ol phase after water-saturated
butan-1-ol/water partition to obtain individual purified GPIs. The
absence of endotoxin in purified GPIs was validated with the
Limulus Amebocyte Lysate kit QCL-100 (Bio-Whittaker, Walkers-
ville, MD). GPIs were stored at 220uC in butan-1-ol until use.
Structural analysis of GPI core glycans
Extracted GPIs were dephosphorylated, deaminated, and
reduced as described elsewhere [40]. Briefly, GPIs were dephos-
phorylated with 48% aqueous hydrofluoric acid for 60 h at 0uC
and the reaction was stopped by blowing off hydrofluoric acid
under a nitrogen stream. Molecules were suspended in 400 ml of
freshly prepared 0.1 M sodium acetate (pH 3.5) containing 0.25 M
NaNO2 and incubated at room temperature (RT) for 4 h. The
reaction was then terminated by addition of 300 ml of 0.4 M boric
acid and 130 ml of 1 M NaOH. The material was reduced
overnight at 4uC using 2 M NaBH4 in 0.3 M NaOH and the
reaction was stopped with 5% acetic acid in methanol that was
removed by two evaporations with 50 ml toluene. The resulting
material was desalted on a Chelex 100 (Na+) - AG50X12 (H+) -
AG3X4 (OH2) - QAE Sephadex A25 (OH2) ion-exchange
column and filtered through a 0.2 mm filter. D-[6-3H]-glucos-
amine-labeled neutral glycans were digested by 2 units of Jack
bean a-mannosidase or N-acetylhexosaminidase in 100 ml of
50 mM sodium acetate (pH 4.5) containing 0.2 mM ZnCl2 and
0.02% sodium azide for 24 h at 37uC [41]. Analysis was
performed by HPAEC using a Bio-LC Dionex module (Dionex
Corporation, Sunnyvale, CA) before and after digestion. Samples
were mixed with 0.6 mg of partially hydrolyzed dextran [42] prior
to injection into a CarbopacH PA1 anion-exchange column
equilibrated with 100 mM NaOH. Elution was accomplished
with 100% buffer A (100 mM NaOH) for 6 min, followed by a
linear increase of buffer B (100 mM NaOH, 0.25 M NaOAc) from
0 to 30% in 30 min at a flow rate of 1 ml/min. Positions of glucose
monosaccharide and oligomer standards were obtained using
pulsed amperometric detection, while eluted radiolabeled glycans
were detected by scintillation counting.
GPI quantification and carbohydrate composition
analysis
The method is based upon quantification of the GlcN residues
of the GPIs being converted to AHM as described elsewhere [43]
with slight modifications. An internal standard of scyllo-inositol was
added to each triplicate sample containing either protein-free GPIs
or GPI-anchored proteins. Controls with various GlcN and myo-
inositol concentrations were prepared and processed in parallel.
Samples were dephosphorylated, deaminated, reduced, and
transferred to glass capillaries in 100 ml methanol-water 1:1 (v/v)
and dried in a vacuum concentrator. Methanolysis was conducted
by adding 50 ml of dry methanol containing 0.5 M HCl, flame
sealing the capillaries under vacuum and incubating them at 95uC
for 4 h. The glass capillaries were opened, pyridine (10 ml) was
added to neutralize the HCl and re-N-acetylation was performed
with acetic anhydride (10 ml) for 30 min at RT. Samples were
dried twice from dry methanol (20 ml) in a vacuum concentrator.
Derivatization was performed with 10 ml of TMS (trimethylchlor-
osilane-hexamethyldisilazane-dry pyridine, 1:3:10, v/v) for 20 min
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prior to analysis of 2 ml of the products by GC-MS on a MS
detector-5973 (GC-6890N, Agilent Technologies, Santa Clara,
CA) with a HP-5 column (30 m625 mm) at 80uC for 2 min
followed by a gradient up to 140uC at 30uC/min and a second
gradient up to 265uC at 5uC/min and held at 265uC for a further
10 min. Ion monitoring of m/z 273 was selected to detect AHM
and m/z 318 to detect both scyllo- and myo-inositol. The peak areas
of the corresponding standards were used to calculate the molar
relative response, allowing quantification of both AHM and myo-
inositol in the samples. The same method was used to determine
monosaccharide content. Analyses were conducted in triplicate on
0.5 nM of myo-inositol containing glyconjugate/glycoprotein, with
1.0 nM scyllo-inositol as an internal standard. A mixture of sugar
standards (each at 0.5 nM) was run in parallel to determine the
molar relative response factor.
Structural analysis of PIs
Extracted GPIs were subjected to deamination, followed by
organic extraction prior to analysis by ES-MS on a Quattro
Ultima triple quadrapole instrument. MassLynx was used to
record and process the data [44].
Immunofluorescence microscopy
HFF (ATCC) cells were grown to confluence on glass coverslips
and infected either with T. gondii RH or PTG strains. Cells were
fixed (48 h post infection, h p.i.) with 4% paraformaldehyde and
subsequently permeabilized with 0.02% Triton-X 100, 10%
bovine serum albumin (BSA) for 30 min, washed three times with
PBS, and incubated for 1 h in 0.02% Triton-X 100, 10% BSA
with mAb T54 E10 [45] that recognizes the EtN-PO4 and
GlcGalNAc epitopes of protein-free GPIs [35]. Cells were washed
again for three times with PBS and incubated for 1 h with
secondary FITC-conjugated anti-mouse immunoglobulin anti-
body (DakoCytomation, Glostrup) in 0.02% Triton-X 100, 10%
BSA. Finally, cells were washed three times with PBS and
mounted in Fluoprep (BioMe´rieux, Marcy-l’Etoile).
Cytokine measurements
RAW 264.7 (ATCC) and J774 (ATCC) mouse macrophages
were used to measure TNF-a or IL-12p40 levels, respectively.
Macrophages were incubated with protein-free GPIs purified by
TLC from the RH or PTG strain. For that purpose, the GPI
material needed was dried under a stream of nitrogen to volatilize
the butan-1-ol. The GPIs were suspended by sonication in
PANSERIN 401 serum-free medium. Measurements of TNF-a
and IL-12p40 in cell culture supernatants were determined using a
specific sandwich ELISA (BD Pharmingen), following the manu-
facturer’s directions. GPIa, a chemically synthesized GPI molecule
of T. gondii [46] kindly provided by Prof. Richard R. Schmidt
(Department of Chemistry, University of Konstanz, Germany),
was tested on J774 cells.
NF-kB p65 transcription factor assay
RAW 264.7 macrophages were stimulated for 15, 30, and
60 min with or without protein-free GPIs purified from 46108
parasites of the PTG strain or with medium alone. Macrophage
proteins were extracted and activation of NF-kB was measured
using the TransAMTM NF-kBp65 transcription factor assay kit
according to the manufacturer’s instructions (Active Motif,
Rixensart).
FACS analysis
The CHO reporter cell lines (CHO/CD14, expressing endog-
enous functional TLR4; 7.19/CD14/TLR2, expressing stably
transfected human TLR2; and the 7.19 clone, expressing neither
TLR2 nor functional TLR4) contain a cd25 gene reporter under
the control of the human E-selectin promoter, which contains an
NF-kB-binding site [47,48]. The CHO reporter cell lines were
generated as described elsewhere [48]. Cells were plated at 16105
per well in 24-well tissue-culture dishes. After 18 h stimulation
with medium alone or with protein-free GPIs purified from 16109
parasites of the PTG strain, cells were stained with PE-labeled
anti-CD25 (mouse mAb to human CD25, PE conjugate; Caltag
Laboratories, Burlingame, CA), examined by FACS analysis and
evaluated with CellQuest software (BD Biosciences, San Jose, CA).
Statistical analysis
An unpaired Student t-test was used for statistical evaluation
and P#0.05 was considered statistically significant.
Results
PTG and RH strains synthesize different sets of protein-
free GPIs
We first sought to examine whether the virulent RH strain and
the avirulent PTG strain synthesize identical GPI structures. To
this end, we metabolically labeled these two strains with D-[6-3H]-
glucosamine. Figure 1A shows the separation of [3H]-labeled
protein-free GPIs of both strains by thin layer chromatography
(TLC). The RH strain synthesized six different GPI structures with
previously described structures [35]. In contrast, the PTG strain
synthesized only four major GPIs that seem to correspond to GPIs
II, III, V and VI of the RH strain. The Glc-GalNAc-substituted
GPIs I and IV were strongly reduced to near background levels in
the PTG strain (Figure 1A). The peaks of both strains migrated
with nearly identical Rf (rate of flow) values, suggesting only minor
differences in their structures (Figure 1A).
GPIs of PTG and RH strains have similar core glycan
structures
To investigate whether the protein-free GPIs synthesized by the
PTG strain are structurally similar to those of the RH strain, we
first analyzed their core glycan structures. The GPIs II, III, V and
VI of the PTG strain were individually subjected to dephosphor-
ylation, deamination and reduction to generate Man3-anhydro-
mannitol (AHM) core glycans. They were then analyzed by high-
performance anion-exchange chromatography (HPAEC) together
with an internal dextran hydrolysate standard (dextran unit, DU).
All four core glycans co-eluted with the 3 DU standard (Figure 2A,
upper panel), similar to those of the RH strain [35]. To detect the
presence of a-D-mannosyl residues, core glycans were individually
digested with a-mannosidase. Core glycans individually treated
with a-mannosidase eluted at 2.4 DU instead of 0.9 DU, the
elution position of AHM (Figure 2A, middle panel). This
incomplete digestion suggests the presence of a non-mannose
substituent linked to the glycan cores, which may represent N-
acetylgalactosamine (GalNAc) bound to GPI core glycan struc-
tures of the RH strain [35]. The presence of GalNAc residues on
PTG strain core glycans was assessed by N-acetylhexosaminidase
digestion. The core glycans derived from GPIs II and V were
resistant to digestion with N-acetylhexosaminidase (elution at 3
DU, Figure 2A, lower panel), whereas core glycans derived from
GPIs III and VI were sensitive to this treatment (elution of Man3-
AHM at 2.5 DU and of GalNAc at 1 DU, Figure 2A, lower panel).
GPIs of Virulent and Avirulent Toxoplasma Strains
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This suggests the presence of an extra residue that is linked to the
GalNAc, thus hindering its enzymatic removal by N-acetylhex-
osaminidase, which is similar to GPIs II and V of the RH strain
that have an additional Glc residue [35]. We propose that the
GPIs of the PTG and RH strains have similar GPI core glycan
structures, namely Man-Man-(Glc-GalNAc)Man-anhydromanni-
tol for GPIs II and V, and Man-Man-(GalNAc)Man-anhydro-
mannitol for GPIs III and VI (Figure 2B).
GPIs of RH and PTG strains have similar PI structures
We next analyzed the structures of the phosphatidylinositols (PI)
moieties of the protein-free GPIs from both RH and PTG strains
by negative ion electrospray mass spectrometry (ES-MS). The ES-
MS analysis revealed that the PI moieties from both strains were
very similar, with the vast majority of the heterogeneous PI species
containing a sn-2 C18:1 acyl chain (Figure 2C, and Table S1). The
two most abundant PI species found in both RH and PTG strain
GPIs were C34:1 (C16:0, C18:1; 835 m/z) and C36:2 (C18:1,
C18:1; 861 m/z). The only significant difference was the increased
abundance of the PI species at 889 m/z, C38:2 (C20:1, C18:1) in
GPIs of the PTG strain (Figure 2C). This difference in
heterogeneity was also observed in PI moieties obtained from
the protein-anchoring GPIs of both strains (data not shown).
Glc-GalNAc-substituted GPIs of RH and PTG strains are
exclusively present on extracellular parasites
We have previously shown that the Glc-GalNAc-substituted
GPIs remain protein-free and clustered in detergent resistant
membrane domains (DRMs) that are enriched in cholesterol and
sphingolipids, whereas the GalNAc-substituted GPIs are used to
anchor surface proteins in RH strain parasites [32]. To investigate
the distribution pattern of protein-free Glc-GalNAc-substituted
GPIs in the PTG strain, we performed parasite labeling with mAb
specific for the EtN-PO4 and the Glc-GalNAc side-branch of
GPIs. Figure 3 illustrates that protein-free Glc-GalNAc-substituted
GPIs are present on parasites of the PTG strain with similar
distribution pattern and to the level found on the surface of RH
strain parasites. Interestingly, we could not detect any labeling
specific for protein-free Glc-GalNAc-substituted GPIs on intracel-
lular parasites, whatever the strain type. This could be due to an
insufficient permeabilization procedure before labeling. To
exclude this possibility, the labeling procedure was repeated with
both intracellular parasites mechanically released from their host
cells and extracellular parasites harvested from cell culture
supernatants. This approach confirmed that the Glc-GalNAc-
containing GPIs are exclusively found on extracellular parasites
(Figure S1). The labeling of the main surface protein SAG1
confirmed the accessibility and integrity of parasite surface
molecules (Figure S1).
RH strain has more protein-free GPI and protein-
anchored GPI content than the PTG strain
To evaluate quantitative difference between GPIs of both
strains, we analyzed both protein-free GPIs and protein-anchored
GPIs of RH and PTG strains by gas chromatography-mass
spectrometry (GC-MS). The method is based upon quantification
of the GlcN residues of the GPIs being converted to AHM [43].
The close correlation between the AHM and the myo-inositol
content of the GPIs indicated a high quality of the extraction and
purification methods employed (Table 1). This analysis revealed
that the PTG strain had about 70% of the total amount of GPI-
anchored proteins of the RH strain, while the total protein-free
GPI content was reduced to 34%, most probably due to the
missing GPI I and IV. This quantitative reduction of GPI-anchor
content in the PTG strain may lead to a reduction of SRS and/or
SUSA proteins. Non-quantitative peptide-mass fingerprinting
analysis of the GPI-anchored proteins identified identical SRS
proteins, namely SAG1, SAG2, and SRS3 in both strains (Table
S2) despite different SDS/PAGE profiles of GPI-anchored protein
fractions of both strains (Figure S2). Together, the quantitative
comparison of AHM revealed that the RH strain has significantly
higher protein-free GPI, as well as protein-anchored GPI content
than the PTG strain.
GPI-anchored proteins of the RH strain have a higher
degree of N-glycosylation than GPI-anchored proteins of
the PTG strain
To determine whether the glycosylation rates of protein-free
GPIs and GPI-anchored proteins correlate with the GPI content,
we compared protein-free GPIs and GPI-anchored proteins of
both strains for altered glycosylation levels by GC-MS. The
carbohydrate composition analysis of protein-free GPIs of the RH
and PTG strains revealed a molar ratio of Ino:Man:GlcNAc:Gal-
Figure 1. RH and PTG strains have different GPI profiles. (A)
Metabolically labeled ([3H]-glucosamine) parasite glycolipids were
extracted and separated by TLC as described in Materials and Methods.
TLC chromatograms were scanned for radioactivity using a Berthold LB
2842 linear analyzer. Six different peaks representing individual GPIs are
detected in the RH strain [35], whereas only four major peaks are
present in the PTG strain. (B) Structures of T. gondii RH GPIs. GPI VI
(Man-Man-[GalNAc]Man-GlcN-PI) is neither substituted with an EtN-PO4
nor with the Glc linked to the GalNAc residue. GPIs I, II and III contain an
EtN-PO4 residue (dashed frame line). GPIs I, II, IV and V are substituted
with a Glc that is linked to the GalNAc side-branch in a1–4 linkage
(thickened frame line). GPIs I, II and IV, V, respectively, have identical
carbohydrate moieties and differ in their fatty acid composition.
doi:10.1371/journal.pone.0085386.g001
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NAc of 1:3:2:1 and 1:3:1:1, respectively (Table 2). Significant
higher molar ratios of glucose were detected in protein-free GPIs
of the RH strain (Table 2). This is consistent with the TLC-
analysis of metabolically labeled PTG strain GPIs that demon-
strated that two of four Glc-GalNAc-substituted GPIs were
dramatically reduced in this strain (Figure 1A). We also found
unexpected presence of galactose, fucose, and xylose in protein-
free GPIs with higher molar ratios for the RH strain. The latter
may be evidence of co-purification of an as yet unidentified
glycoconjugate or a minor contamination by a GPI-anchored
protein, which is N- and/or O-glycosylated. The analysis of RH
and PTG GPI-anchored proteins revealed an average of N- and
possibly O-glycosylation with higher molar ratios of mannose and
GlcNAc in RH GPI-anchored proteins (Table 2). These results
Figure 2. GPI core glycans and PIs of RH and PTG strains have similar structures. (A) HPAEC analysis of the core glycans generated from T.
gondii PTG strain protein-free GPIs II, III, V and VI. TLC-purified D-[3H]-glucosamine labeled GPIs were dephosphorylated, deaminated and reduced.
The resulting neutral glycans were analysed before (untreated) and after Jack bean a-mannosidase or hexosaminidase treatments. The elution
positions of the co-injected glucose oligomer standards are indicated at the top of each profile (bold digits) and given as DU. (B) Predicted Man-Man-
(Glc-GalNAc)Man-anhydromannitol core glycan structure derived from protein-free GPIs II and V (right panel), and predicted Man-Man-(GalNAc)Man-
anhydromannitol core glycan structure derived from protein-free GPIs III and VI (left panel) of the PTG strain. (C) ES-MS spectra of the PI moieties
released by deamination from purified protein-free GPIs from RH (upper panel) and PTG (lower panel) strains.
doi:10.1371/journal.pone.0085386.g002
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suggest that the RH strain possesses a significantly higher degree of
N- and possibly O-glycosylation in GPI-anchored proteins than
the PTG strain.
Protein-free GPIs of RH and PTG strains stimulate
comparable levels of TNF-a and IL-12 secretion
The six protein-free GPIs of the RH strain have been shown to
stimulate macrophages to secrete TNF-a [23]. To measure the
biological activity of the four protein-free GPIs of the PTG strain,
we individually added them to macrophage cultures. All four PTG
GPIs induced significantly the secretion of TNF-a by macrophages
(Figure 4A) to a similar extent than those of the RH strain [23]. An
early production of IL-12 is essential for the host resistance against
T. gondii in mice and only few parasite-derived molecules have
been identified to induce IL-12 production [49,50]. We therefore
tested whether the protein-free GPIs of both strains could induce
the secretion of IL-12 by macrophages. Figure 4B shows that all
GPIs purified from RH (left panel) and PTG (right panel) strain
parasites induced significantly the secretion of IL-12 by macro-
phages. Importantly, glycolipids extracted from uninfected host
cells as well as silica alone did not stimulate any cytokine secretion,
suggesting that this activity is specific for T. gondii GPIs [23]. To
further validate whether the IL-12 production is specifically
induced by GPIs and not due to a contaminating molecule, we
incubated macrophage cultures with GPIa [(EtN-PO4)-Mana1-
2Mana1-6 (Glca1-4GalNAc b1-4)Mana1-4GlcNa-inositol-PO4],
a chemically synthesized structure of RH strain GPI III core
glycan. GPIa induced the production of IL-12, thereby demon-
strating that the production of IL-12 in response to GPIs is specific
and not due to a contaminating molecule (Figure 4C). In sum,
these data suggest that RH and PTG GPIs have similar
inflammatory capacities due to similar structures.
Protein-free GPIs of the PTG strain induce TLR4-
dependent NF-kB activation
In previous work, we showed that all six RH strain GPIs
individually added to CHO/CD14/TLR4 cells induced the
expression of CD25 [36]. To determine whether the four GPIs
of the PTG strain use similar TLR signaling pathways than those
of the RH strain we used two NF-kB reporter cell lines, CHO/
CD14/TLR2 and CHO/CD14/TLR4, co-expressing CD14 and
TLR2 or TLR4, respectively. No induction of CD25 expression
was observed on control cells when stimulated with individual
PTG strain GPIs (Figure 5A, left panel). Low CD25 expression
levels were measured when PTG strain GPIs were individually
incubated with CHO/CD14/TLR2 cells (Figure 5A, middle
panel). The expression of CD25 was activated significantly on
CHO/CD14/TLR4 cells (Figure 5A, right panel) with magni-
tudes and kinetics similar to those described for the RH strain
GPIs [36]. The GPI-induced TNF-a expression was previously
shown to rely on the regulatory control of NF-kB p65 in
macrophages [23]. Figure 5B illustrates that the GPIs of the
PTG strain were also able to activate NF-kB p65 in macrophages.
This result suggests that NF-kB p65 mediates the cytokine
production in response to GPIs of the PTG strain. Taken together,
these data indicate that RH and PTG strain GPIs have similar
inflammatory capacities, mediated by comparable TLR/NF-kB-
dependent signaling.
Discussion
In the present work, we demonstrate that the GPIs of the
virulent T. gondii RH and the avirulent PTG strains have similar
structures and induce comparable biological effects in macro-
phages but differ in terms of total GPI-anchor content and degree
of GPI-anchored protein N-glycosylation, both were significantly
increased in the virulent RH strain. These findings are in line with
several earlier studies that have shown that purified GPIs from
protozoan parasites are able to activate immune cells of both
myeloid and lymphoid origin [51]. In earlier work, we demon-
strated that GPIs of RH and PTG strains bind with similar high
affinities to human galectin-3 that is required to induce TNF-a
secretion by macrophages in response to T. gondii GPIs [37].
Herein we showed that purified and individually tested GPIs from
RH and PTG strains induce comparable secretion levels of TNF-a
and IL-12 by macrophages, likely as a result of almost identical
structures of GPI core glycans and lipid moieties. We showed
further that the GPIs of the PTG strain activate TLR4 in a NF-kB
CHO/CD14 reporter cell line with comparable magnitudes to
those of the RH strain, suggesting that the cytokine induction is
due to identical signaling events initiated by macrophage TLRs
[36]. The GPIs of both strains have been also shown to stimulate
the synthesis of matrix metalloproteinase (MMP)-9 by macro-
phages in a TNF-a-dependent manner and to degrade extracel-
lular galectin-3 [52]. The GPI-induced degradation of galectin-3
by MMP-9 could have a regulatory function on TLR-signaling in
response to GPIs [52]. We conclude that GPIs of RH and PTG
Figure 3. Protein-free Glc-GalNAc-substituted GPIs are clus-
tered on extracellular parasites. Staining after permeabilization of
HFF cells infected (72 h p.i.) with RH (upper panel) and PTG (lower
panel) strains was performed using mAb T54 E10, recognizing both the
EtN-PO4 and the Glc-GalNAc side-branch epitopes of protein-free GPIs.
Filled arrowheads point to intracellular parasites residing inside
parasitophorous vacuoles. Unfilled arrowheads point to extracellular
parasites. DIC, differential interference contrast.
doi:10.1371/journal.pone.0085386.g003
Table 1. Comparison of AHM and inositol quantifications of
protein-free GPIs and GPI-anchored proteins of RH and PTG
strains.
Sample AHM quantificationa Inositol quantificationa
RH protein-free GPIs 4.2560.216106 4.5460.166106
PTG protein-free GPIs 1.4660.136106 (34%) 1.8460.226106 (41%)
RH GPI-anchored proteins 1.1260.116106 1.4260.266106
PTG GPI-anchored
proteins
0.7860.046106 (70%) 1.0260.076106 (72%)
aCopies per cell. In parentheses are percentages of PTG values compared to RH
values. Values are means 6 SD of three replicates.
doi:10.1371/journal.pone.0085386.t001
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Table 2. Carbohydrate composition analysis of protein-free GPIs and GPI-anchored proteins of RH and PTG strains.
Sample Ino Man GlcNAc GalNAc Gal Glca Fuc Xyl
RH protein-free
GPIs
1.060.1 3.961.1 2.560.7 1.260.3 2.661.4 5.662.2 2.560.3* 1.260.1**
PTG protein-free
GPIs
1.060.1 3.260.4 1.660.3 0.760.2 0.460.1 2.360.7 0.860.2 0.660.1
RH GPI-anchored
proteins
1.060.1 18.963.2* 7.360.6* 1.460.3 6.361.2 14.163.9 7.660.1 8.061.0
PTG GPI-anchored
proteins
1.060.1 9.362.6 4.561.1 1.260.1 4.161.9 15.164.1 5.560.5 7.260.8
aGlucose is a common contaminant. Values are means of molar ratios 6 SD of three replicates.
Values are means of molar ratios 6 SD of three replicates.
**P,0.005,
*P,0.05 RH protein-free GPI and GPI-anchored protein samples compared to PTG protein-free GPI and GPI-anchored protein samples, respectively.
doi:10.1371/journal.pone.0085386.t002
Figure 4. GPIs of RH and PTG strains induce TNF-a and IL-12p40 secretion by macrophages. (A) Macrophages were incubated for 24 h
with medium alone, or with individual GPIs of the PTG strain extracted from 16108 parasites and assayed for TNF-a cytokine production. (B)
Macrophages were incubated for 24 h with medium alone, or with individual GPIs of the RH (left panel) and the PTG strain (right panel) extracted
from 26108 parasites, respectively, and assayed for IL-12p40 cytokine production. (C) Macrophages were incubated for 24 h with medium alone, or
with GPIa (3 mM), a chemically synthesized structure of RH strain GPI III core glycan and assayed for IL-12p40 cytokine production. ***P,0.0005 PTG
GPI II compared to medium control. ND, not determined.
doi:10.1371/journal.pone.0085386.g004
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strains activate similar signaling events in macrophages due to
similar structures.
Structural differences between GPI core glycans of both strains
may nevertheless exist since acid-labile residues, such as
phosphate, phosphate glycans or phosphoethanolamine, removed
by the acidic treatments are not detected. The presence of sn-2
fatty acids (C18:1) in the T. gondii GPIs found here and elsewhere
[44] is reminiscent to the immunogenic GPIs in Plasmodium
falciparum mid-schizont stages, which incorporate C18:1 (88%) and
C18:2 (12%) at the sn-2 position of their diacylglycerolipid [53],
and in Trypanosoma cruzi trypomastigotes GPIs, which contain
C16:0 (37%), C18:1 (31%) along with C18:2 (21%) at their sn-2
position of their alkylacylglycerolipid [54]. We reasoned that
strain-specific differences in the GPI composition could be due to
Figure 5. GPIs of the PTG strain activate TLR4/NF-kB signaling. (A) CHO cells expressing TLR2 (TLR2+), TLR4 (TLR4+), or neither (TLR22/TLR42)
were either untreated (black line) or exposed to the four different GPIs (II, III, V and VI) extracted from 16109 parasites (gray line). CD25 expression
was measured by FACS analysis 18 h after stimulation. The figure is representative of three independent experiments. Percentage= [percentage of
CD25 expression (M2) on GPI-stimulated cells] minus [percentage of CD25 expression (M2) on medium stimulated cells]. (B) Macrophages were
incubated for 15, 30, or 60 min with GPI VI extracted from 46108 PTG strain parasites. Total nuclear protein content was tested using a NF-kB assay as
described in Materials and Methods. The figure is a representative experiment with PTG GPI VI and similar results were obtained with GPIs II, III and V
of the PTG strain. **P,0.005 compared to medium control.
doi:10.1371/journal.pone.0085386.g005
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different amounts of protein-free GPIs and/or particular GPI-
anchored surface proteins. The comparative analysis of total GPI
content demonstrated that the PTG strain had significantly lower
quantities of both protein-free GPIs and GPI-anchored proteins,
which is likely due to extremely low levels of GPIs I and IV and
not because of structural differences in the parasite form between
the two strains [55]. The molecular mechanisms and the biological
significance underlying the apparent lack of GPIs I and IV in the
PTG strain are unknown and have yet to be established. Of
further interest would be to analyze the GPI biosynthesis of T.
gondii strains other than RH and PTG to verify whether the
observed differences in the GPI content represent a general
phenomenon between virulent and avirulent strain types. The bulk
carbohydrate composition analysis of total GPI-anchored proteins
revealed that the molar ratios of Man and GlcNAc are almost
twice as high in the RH strain than in those of the PTG strain.
Low molar amounts of GalNAc suggest evidence of O-glycosyl-
ation in GPI-anchored proteins. Alternatively, the fucose with
xylose, galactose and possibly glucose, may form part of a yet
unidentified glycan structure that may either be co-purified with
the GPI-anchored proteins, or is part of a glycoprotein. In
summary, these data suggest that N-linked glycosylation is more
extensive in GPI-anchored proteins of the virulent RH strain than
in those of the avirulent PTG strain. These results do not,
however, demonstrate whether there are specific heavily N-
glycosylated GPI-anchored protein(s) missing in the avirulent
strain or generally there is less glycosylation of the same GPI-
anchored protein(s) (Fauquenoy et al., 2008). Recent work has
shown that members of the SRS gene family are polymorphic,
codominantly and differentially expressed as distinct, largely
nonoverlapping sets of SRS antigens in a parasite strain type-
and developmental-stage-specific manner [33]. The biological
roles of most SRS and SUSA proteins remain largely understud-
ied, however, some have been reported to function as virulence
determinants, involved in parasite adhesion and invasion of host
cells (SAG3) [56] and stimulation of host immunity (SAG1)
[57,58]. Recently it has been demonstrated that targeted deletion
of the SRS29B (SAG1) and SRS34A (SAG2A) genes in the RH
strain led to a specific and substantial increase in SRS29C (SRS2)
protein surface expression to a level found on the surface of type 2
strain parasites, resulting in an attenuated virulence phenotype in
the mouse model. It was hypothesized that decreased virulence is
related to an altered immune response towards fine-tune and/or
dampening the inflammatory capacity of other immunoreactive
SRS proteins such as SRS29B (SAG1) [33]. Interestingly, our non-
quantitative peptide-mass fingerprinting analysis of GPI-anchored
proteins revealed that the most abundant parasite-specific SRS
proteins, namely SAG1, SAG2, and SRS3 but not SRS2 were
present in both strains, whereas the SDS-PAGE analysis of RH
and PTG strain GPI-anchored protein fractions clearly showed
several differences in the protein distribution pattern, which
however could also reflect N-glycosylation differences. Further
studies are required to identify and unravel the biological function
of these differently expressed proteins in GPI-anchored protein
fractions of both strains, including attempts to alter gene
expression and targeted gene deletion, followed by testing their
relevance in virulence and pathogenesis in the mouse model. The
protein-free Glc-GalNAc-substituted GPIs were found equally
present and arranged as clusters only in extracellular parasites of
both RH and PTG strains. We therefore speculate that protein-
free GPIs have dual functions in stimulating host immunity and/or
functions in parasite adhesion of target host cells. Several studies
have shown that protein-free GPIs or glycoinositolphospholipids
(GIPLs) containing ceramides of protozoan parasites elicit a
detrimental stimulation of the host innate immune system [51].
We have previously demonstrated that protein-free GPIs contain-
ing the Glc-GalNAc side-branch are highly immunogenic in
animals and are responsible to elicit an early IgM response in
humans [32,35,59]. Furthermore, we found that protein-free GPIs
are components of DRMs with enrichments of proteins involved in
parasite motility and host cell invasion [32]. Further studies are
needed, however, to determine whether protein-free Glc-GalNAc-
substituted GPIs have indeed dual roles in stimulating the host
immunity and functions in host cell invasion as previously
proposed for T. gondii profilin [60].
Supporting Information
Figure S1 Protein-free Glc-GalNAc-substituted GPIs are
clustered and exclusively present on extracellular par-
asites. Parasites were collected from cell culture supernatants,
while intracellular parasites were mechanically released from host
cells with glass beads in a Mixer Mill homogenizer. Parasites were
purified, separately fixed on microscope slides with CellTack (BD
Biosciences), and stained with the mAb T54 E10 as described in
Materials and Methods without initial permeabilization. The mAb
T4 1E5, specific for the major T. gondii surface protein SAG1 was
used as control. Slides were examined on a Zeiss Axiophot 200M
microscope equipped with ApoTome (Carl Zeiss Inc.).
(PDF)
Figure S2 Comparison of T. gondii RH and PTG strain
GPI-anchored protein fractions. GPI-anchor protein fraction
was obtained after the protein-free GPI extraction from the same
parasite pellet by two extractions with water-ethanol-diethylether-
pyridine-ammonium hydroxide (15:15:5:1:0.017, by volume).
Extracts were pooled and dried under a stream of nitrogen and
solubilized in Laemmli-sample buffer and boiled for 5 min. Equal
amounts of GPI-anchored protein fractions of both strains were
electrophoresed on 10% (w/v) SDS–PAGE and proteins were
stained with Coomassie Blue. The filled arrowhead points to the
expected size of SAG1 (P30) protein.
(PDF)
Table S1 Assignment table of Figure 2C. ES-MS analysis
of the PI moieties released by deamination from purified protein-
free GPIs from RH and PTG strains. aAll of the molecular species
refer to the corresponding peaks in the negative ion mode in
Figure 2C. The peaks containing the most abundant species are in
bold. bObserved [M-H]-ions, mass over charge from survey scans
as described in the experimental procedure section. cPeak
identities refer to total number of carbon atoms and double
bonds. dOnly the principal component is given. eTheoretical
monoisotopic masses were obtained when possible with LIPID-
MAPS, otherwise they were calculated using http://www.sisweb.
com/referenc/tools/exactmass.htm.
(PDF)
Table S2 Analysis of RH and PTG strain GPI-anchored
proteins. Results obtained from mass-fingerprinting of a fraction
containing purified GPI-anchored proteins from both RH and
PTG strains. The GPI-anchor protein fraction was obtained after
the protein-free GPI extraction from the same parasite pellet by
two extractions with water-ethanol-diethylether-pyridine-ammo-
nium hydroxide (15:15:5:1:0.017, by volume). The supernatant
was dried under a stream of nitrogen and proteins were re-
suspended in trypsin digestion buffer [12.5 mg/ml modified
bovine trypsin (Roche), 0.1% n-octyl glucoside (Calbiochem),
20 mM ammonium bicarbonate]. An equal volume of acetoni-
trile/0.3% trifluoroacetic acid was added to extract the peptides.
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MALDI mass spectra were generated using a Voyager DE-STR
MALDI-TOF MS system (PerSeptive Biosystems) with delayed
extraction in the reflectron mode. Protein identification was from a
comparison of peak list data generated from the Data Explorer
application (PerSeptive Biosystems) against NCBInr (non-redun-
dant) and Swissprot databases using the Protein-Prospector V3.4.1
software MS-Fit (http://www.prospector.ucsf.edu). Only hits with
a high score are given so that a very high confidence level could be
maintained, with major surface proteins in bold.
(PDF)
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